Sweden
· Delayed Price · Currency is SEK Medclair AB Statistics
Total Valuation
Medclair AB has a market cap or net worth of SEK 103.12 million. The enterprise value is 101.21 million.
| Market Cap | 103.12M |
| Enterprise Value | 101.21M |
Important Dates
The last earnings date was Friday, November 1, 2024.
| Earnings Date | Nov 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Medclair AB has 82.49 million shares outstanding. The number of shares has increased by 29.08% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 82.49M |
| Shares Change (YoY) | +29.08% |
| Shares Change (QoQ) | -3.58% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 25.84 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -98.74 |
| EV / Sales | 2.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 25.36 |
Financial Position
The company has a current ratio of 2.06
| Current Ratio | 2.06 |
| Quick Ratio | 0.96 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -5.98% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 3.11M |
| Profits Per Employee | -73,214 |
| Employee Count | 14 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.77 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.14% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -16.14% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 1.46 |
| Relative Strength Index (RSI) | 34.48 |
| Average Volume (20 Days) | 227,308 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medclair AB had revenue of SEK 43.53 million and -1.03 million in losses.
| Revenue | 43.53M |
| Gross Profit | 26.27M |
| Operating Income | -5.83M |
| Pretax Income | -1.02M |
| Net Income | -1.03M |
| EBITDA | -1.32M |
| EBIT | -5.83M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | 1.91M |
| Total Debt | n/a |
| Net Cash | 1.91M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | 9.94M |
Cash Flow
In the last 12 months, operating cash flow was 4.12 million and capital expenditures -132,000, giving a free cash flow of 3.99 million.
| Operating Cash Flow | 4.12M |
| Capital Expenditures | -132,000 |
| Free Cash Flow | 3.99M |
| FCF Per Share | 0.05 |
Margins
Gross margin is 60.35%, with operating and profit margins of -13.39% and -2.35%.
| Gross Margin | 60.35% |
| Operating Margin | -13.39% |
| Pretax Margin | -2.33% |
| Profit Margin | -2.35% |
| EBITDA Margin | -3.03% |
| EBIT Margin | -13.39% |
| FCF Margin | 9.17% |
Dividends & Yields
Medclair AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.08% |
| Shareholder Yield | -29.08% |
| Earnings Yield | n/a |
| FCF Yield | 3.87% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |